UnitedHealth Group (NYSE:UNH) Shares Unloaded Rep. David Taylor

Representative David Taylor (R-Ohio) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on June 02nd, the Representative disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on May 14th. The trade occurred in the Representative's "DAVID TAYLOR TRUST > SARDINIA READY MIX 401(K) - DAVE" account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Installed Building Products NYSE: IBP on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 5/14/2025.
• Sold $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Fifth Third Bancorp NASDAQ: FITB on 5/14/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 5/13/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 5/12/2025.
• Purchased $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 5/12/2025.
• Purchased $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 3/27/2025.
• Purchased $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 3/10/2025.
• Purchased $1,001 - $15,000 in shares of JPMorgan Chase & Co. NYSE: JPM on 3/10/2025.

UnitedHealth Group Stock Performance

UNH traded down $4.77 on Thursday, reaching $295.61. The company had a trading volume of 12,405,237 shares, compared to its average volume of 10,891,771. The stock has a 50-day moving average price of $418.00 and a 200-day moving average price of $488.12. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The stock has a market capitalization of $268.16 billion, a PE ratio of 19.07, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm posted $6.91 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.99%. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Insider Buying and Selling

In other UnitedHealth Group news, CFO John F. Rex bought 17,175 shares of the stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.33% of the company's stock.

Hedge Funds Weigh In On UnitedHealth Group

A number of large investors have recently bought and sold shares of the stock. Norges Bank purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $6,375,744,000. GAMMA Investing LLC lifted its position in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares in the last quarter. Nuveen LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter valued at $3,846,764,000. Vanguard Group Inc. increased its holdings in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $1,914,740,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Raymond James cut shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Oppenheimer dropped their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Finally, Morgan Stanley reduced their price target on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $428.43.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio's 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Taylor (Republican Party) ran for election to the U.S. House to represent Ohio's 2nd Congressional District. He won in the general election on November 5, 2024. David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor's career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.